RJFSA
HRMY icon

Raymond James Financial Services Advisors’s Harmony Biosciences HRMY Stock Holding History

Raymond James Financial Services Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.22M Sell
30,571
-15,554
-34% -$546K ﹤0.01% 2027
2024
Q2 		$1.39M Buy
46,125
+16,308
+55% +$490K ﹤0.01% 1882
2024
Q1 		$1M Buy
+29,817
New +$957K ﹤0.01% 2060

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial Services Advisors's HRMY Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Harmony Biosciences (HRMY) stake by 34% in Q3 2024, selling an estimated $546K and leaving 30,571 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Raymond James Financial Services Advisors first reported a position in HRMY in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.39M in Q2 2024. 233 funds tracked by Wall St. Rank hold HRMY as of Q3 2024.

  • Raymond James Financial Services Advisors held 30,571 shares of Harmony Biosciences worth $1.22M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 15,554 Harmony Biosciences shares in Q3 2024, an estimated $546K.
  • Harmony Biosciences made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2027 holding.
  • Raymond James Financial Services Advisors first reported a position in Harmony Biosciences in Q1 2024 and has held it in 3 quarters since.
  • Raymond James Financial Services Advisors's Harmony Biosciences position peaked at $1.39M in Q2 2024.
  • 233 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.